Global medical packaging company SteriPack Group is set to extend its implementation of QAD Enterprise Applications Life Science Edition.
The company is implementing QAD Enterprise Applications at its first US based operations, with existing implementations in Ireland, Poland and Malaysia.
SteriPack USA president Tony Paolino said QAD Enterprise Applications offer the company business process continuity across all of its facilities.
"Extending QAD to SteriPack USA enables us to rapidly onboard new operations that can run at peak performance to deliver consistent supply to our medical device customers," Paolino said.
QAD Enterprise Applications is available in multiple languages with multi-tiered on-premise QAD On Demand software as a service (SaaS) and hybrid deployment options.
The edition implemented from software and services provider QAD, supports critical quality requirements, including regulatory compliance, CAPA, and device history/electronic batch record requirements.
Designed for single or multi-site operations, the edition accommodates different production models, plant locations and financial structures for global manufacturing companies in more than 90 countries and 27 languages.
